Phase 3 noninferiority RCT in 214 evaluable HSCT or acute leukaemia patients, stopped at second interim analysis: major infections 31.4% with liberalised diet vs 20.2% with neutropenic diet; no gain in calories, quality of life or survival.
Clinical trialn = 214
Wingard et al. Randomized Noninferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem-Cell Transplant Patients and Patients With Acute Leukemia